leisure time -WSS

leisure time

author：Wikipedia 2025-09-27 16:46:10 - browse：88

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Longer MASH drug regimen improved liver, Akero study finds

explore

WSS

Streamlined flu vaccines recommended by FDA advisory panel

$1 billion proposal to grow Boston, Massachusetts biotech

Medicare drug price negotiation hearing pits pharma v Biden admin

Immune cells and nerve overgrowth may explain recurring UTI pain

Ancient Greek ideas underpin modern concepts of pregnancy

Florida health officials providing scant details on measles cases

hotspot

leisure time

focus

Drug repurposing or repositioning? The language matters

Stem cell biologist probes earliest stages of human development

Hepatitis C has a cure — but many Americans still lack access to it

Streamlined flu vaccines recommended by FDA advisory panel

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

He's 19 months old and has one of the world’s rarest diseases

In Memoriam: Notable people who died in 2023

For AI in health care standards, federal regulators join with industry group

Alkermes shareholders re

Longer MASH drug regimen improved liver, Akero study finds

leisure time

Pregnant women don't need prenatal multivitamins, study concludes

He's 19 months old and has one of the world’s rarest diseases

Ancient Greek ideas underpin modern concepts of pregnancy

Fetal cell organoids grown from amniotic fluid, study finds

Ozempic has benefits for kidney disease as well as diabetes

Medicare drug price negotiation continues, as pharma counteroffers

entertainment

explore

knowledge

explore